Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Skin Cancer Risk Linked to Xeljanz, Jakafi, Other JAK Inhibitors: Study Xeljanz, Jakafi and other JAK inhibitors were linked to an increased risk of melanoma, squamous cell carcinoma and Merkel cell carcinoma May 18, 2022 Irvin Jackson Add Your Comments Amid increasing concerns in recent years over the side effects of Xeljanz and other JAK inhibitors, which have been linked to an increased risk of cancer, heart attacks, strokes and deadly blood clots, the findings of a new study suggest that the new-generation arthritis treatments may also carry a skin cancer risk. Xeljanz (tofacitinib) was introduced by Pfizer in 2012, as the first member of the JAK inhibitors class of medications, which joined a lucrative market that generates billions in annual sales for treatment of rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Last year, the FDA announced new label warnings about the Xeljanz heart and cancer risks, after evaluating data from a large randomized clinical trial funded by the drug maker, which found users of the drug experienced more cardiovascular events, as well as cancers, pulmonary embolism and death. As a result of the findings, the agency required a label update for Xeljanz, as well as all other drugs in the same new class of medications. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a new study published this month in the medical journal Therapies, French researchers say they have also found an association between the class of medications known as Janus kinase (JAK) inhibitors and skin cancer, including melanoma, squamous cell carcinoma and Merkel cell carcinoma. Researchers indicate that incidents of skin cancer have been reported among patients taking Xeljanz, Jakafi and similar medications, but those risks were not seen in clinical trials used to gain approval for the drugs’ use. To verify the reports, researchers used data from the World Health Organization’s Vigibase international database of suspected adverse drug reactions. They investigated all reports of skin cancers submitted to the French Pharmacovigilance database from 1978 until the end of 2019 linked to Xeljanz, Jakafi and Olumiant. The specifically looked for incidents of melanoma, squamous cell carcinoma and Merkel cell carcinoma. The study found an increased risk linked to all three forms of cancer with the drugs Xeljanz and Jakafi, but only found an increased risk of Merkel cell carcinoma linked to the use of Olumiant, which is another member of the same class. Merkel cell carcinoma risks were more prevalent in immunosuppressed patients and was “associated with a significant disproportionality signal with all the studied JAK inhibitors” the researchers found. “Our study shows that JAK inhibitors could be associated with an extra risk to develop skin cancers,” the researchers concluded. “Considering pharmacovigilance method limitations, further pharmacoepidemiological studies are required to assess a causal link between JAK inhibitors treatment and skin cancer development.” After Xeljanz was introduced, Pfizer aggressively marketed the drug, hoping to take over some of the lucrative market for rheumatoid arthritis treatments, which already included blockbuster drugs like Humira, Enbrel and other TNF inhibitors. Xeljanz was advertised as a safer and more convenient treatment option, and quickly grew to become a top selling drug, with annual sales of more than $2 billion worldwide. However, concerns about serious Xeljanz side effects first emerged in February 2021, after preliminary data was released from a post-marketing study conducted by the drug maker. There are now a growing number former users pursuing a Xeljanz lawsuit against the drug maker, after being diagnosed with cancer, heart attacks, strokes, pulmonary embolism, deep vein thrombosis or other injuries that may have been avoided if earlier warnings had been provided about the potential side effects. Tags: Jakafi, Melanoma, Olumiant, Rheumatoid Arthritis, Skin Cancer, Xeljanz More Xeljanz Lawsuit Stories Xeljanz Side Effects May Cause Weight Gain: Study May 22, 2025 Side Effects of Xeljanz, Rinvoq and Similar Drugs May Increase Risk of Acne: Study November 8, 2023 Cancer Risk with Xeljanz, Other JAK Inhibitors Higher Than Among Users of Older TNF Inhibitors May 1, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025) Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025) Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
Cancer Risk with Xeljanz, Other JAK Inhibitors Higher Than Among Users of Older TNF Inhibitors May 1, 2023
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)